×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| Vanta Bioscience Limited | NA | NA | NA | NA | 17.2 | |
| Gian Life Care Limited | NA | NA | NA | NA | 15.3 | 170.0 |
| Parmax Pharma Limited | NA | NA | NA | NA | 14.5 |
Vanta Bioscience Limited, with Security Code 540729, is a leading player in the Healthcare Research- Analytics & Technology industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2019 | Sep 2019 | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 6.4 | 7.3 | 6.8 | 5.3 | 4.8 | 5.4 | 4.0 | 1.7 | 3.5 | 5.2 |
| Expenses | 4.7 | 5.1 | 4.7 | 3.5 | 2.6 | 4.1 | 2.5 | 1.4 | 4.3 | 3.1 |
| Operating Profit | 1.7 | 2.2 | 2.1 | 1.8 | 2.1 | 1.3 | 1.4 | 0.3 | -0.8 | 2.1 |
| OPM % | 27% | 29.71% | 31.53% | 33.21% | 45.01% | 24.51% | 35.89% | 18.94% | -23.05% | 39.81% |
| Other Income | 0.2 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.6 | 0.0 |
| Interest | 0.9 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.1 | 1.2 | 1.9 | 1.3 |
| Depreciation | 0.3 | 0.4 | 0.8 | 0.6 | 0.6 | 0.0 | 0.7 | 0.6 | 0.6 | 0.6 |
| Profit before tax | 0.6 | 0.8 | 0.5 | 0.1 | 0.5 | 0.3 | -0.2 | -1.5 | -2.7 | 0.2 |
| Tax % | -37.4% | -27% | -19.4% | -66.4% | -10.1% | -22% | -5% | 0.9% | 0.5% | -17.3% |
| Net Profit | 0.4 | 0.6 | 0.4 | 0.0 | 0.4 | 0.2 | -0.2 | -1.5 | -2.7 | 0.1 |
| EPS in Rs | 0.77 | 0.91 | 0.64 | 0.01 | 0.68 | 0.39 | -0.27 | -2.39 | -4.32 | 0.2 |
| Metrics | Sep 2022 |
|---|---|
| Sales | 2.8 |
| Expenses | 3.4 |
| Operating Profit | -0.5 |
| OPM % | -19.37% |
| Other Income | 0.0 |
| Interest | 2.5 |
| Depreciation | 1.3 |
| Profit before tax | -4.3 |
| Tax % | 2.2% |
| Net Profit | -4.4 |
| EPS in Rs | -4.06 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -7% |
| 3 Years: | -4% |
| TTM: | -53% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -55% |
| 3 Years: | -72% |
| TTM: | 48% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -26% |
| 3 Years: | -36% |
| 1 Year: | -67% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -4% |
| 3 Years: | 0% |
| TTM: | -52% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 14% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -26% |
| 3 Years: | -36% |
| 1 Year: | -67% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|